// App-Quantinova.ai

BSH2020‐EP‐091 : Treatment decisions in Waldenstrom's Macroglobulinaemia; outcomes from the South East Scotland Cancer Network

Researchers

Presenter

  • A. Duguid

Principal Investigators

  • O. Pepper

  • F. Scott

Medical Centers

  • Department of Haematology, Western General Hospital, Edinburgh, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Oncology (ONC)

  • Peripheral Nervous System

Disease

  • Non‐Hodgkin Lymphoma

  • Arrhythmia

  • Hodgkin's Lymphoma

  • Thrombocytopenia

  • Peripheral neuropathy

  • Lymphomas

  • Solid malignancies

Biomarkers

  • DNA Damage Inducible Transcript 3

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Bendamustine

  • chlorambucil

  • Ibrutinib

  • Rituximab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved